Tasosartan
- Level
- Commodity
- Parent
- 51433700
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51433703This classification denotes an angiotensin ii type 1 receptor blocker with the molecular formula C23H21N7O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 48G92V856H, chemically known as 5,8-dihydro-2,4-dimethyl-8-(p-(o-1h-tetrazol-5-ylphenyl)benzyl)pyrido(2,3-d)pyrimidin-7(6h)-one but generally known as tasosartan, which bears US NIH Compound Identifier 60919. European Medicines Agency schedules Tasosartan in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10834MIG. World Health Organization schedules tasosartan in its Anatomical Therapeutic Chemical (ATC) Classification. TASOSARTAN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule tasosartan under HS 29337900 and SITC 51561. As of Q4 2014, TASOSARTAN remains the US FDA Preferred Term for this commodity. SMILES: O=C1N(c2nc(nc(c2CC1)C)C)Cc1ccc(cc1)c1c(cccc1)c1n[nH]nn1.
Same parent
Under 51433700 · 8Activities that produce or sell this
KBLI · 8Inherited from family 51430000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.